What is Purity Testing?
Purity testing refers to the analytical processes used to determine the compositional integrity of a synthesised compound, specifically the proportion of the target molecule relative to impurities, by-products, and residual reagents. In the context of research-grade peptides, purity is typically expressed as a percentage and measured using validated analytical techniques.
At Astralis Labs, all compounds are independently tested by accredited third-party laboratories prior to release. Certificates of Analysis (COAs) are available for each batch, providing full transparency on purity specifications and analytical methodology.
Why Purity Matters in Research Settings
The integrity of any research outcome depends on the integrity of the compounds used. Impure peptide preparations introduce variables that can confound experimental results, produce artefactual findings, or render data non-reproducible. Key considerations include:
- Structural Integrity: Peptide synthesis can produce truncated sequences, deletion analogues, or oxidised variants. These structurally distinct species may exhibit different receptor binding profiles, altering experimental outcomes in ways that are difficult to detect without rigorous purity analysis.
- Residual Reagents: Solid-phase peptide synthesis (SPPS) involves a range of chemical reagents including coupling agents, protecting groups, and solvents that must be removed during purification. Residual reagents can interfere with cell-based assays, enzymatic reactions, and in vitro binding studies.
- Batch-to-Batch Consistency: Research reproducibility requires that compounds used across experimental runs are compositionally equivalent. Purity documentation enables researchers to verify consistency between batches and identify potential sources of variability.
- Receptor Selectivity Studies: In studies examining receptor binding specificity, impurities with partial agonist or antagonist activity at off-target receptors can produce misleading pharmacological profiles. High-purity compounds are essential for mechanistic clarity.
Analytical Methods Used in Purity Assessment
Several complementary analytical techniques are employed to characterise peptide purity:
- High-Performance Liquid Chromatography (HPLC): The primary method for quantifying purity by separating the target peptide from impurities based on physicochemical properties. Reverse-phase HPLC (RP-HPLC) is the standard approach for peptide analysis, with purity reported as the area percentage of the target peak relative to total peak area.
- Mass Spectrometry (MS): Confirms the molecular identity of the compound by measuring the mass-to-charge ratio of ionised species. Used in conjunction with HPLC to verify that the primary peak corresponds to the correct molecular weight and sequence.
- Nuclear Magnetic Resonance (NMR): Provides structural confirmation at the atomic level, identifying the presence of specific functional groups and detecting structural anomalies not visible by chromatographic methods alone.
Interpreting a Certificate of Analysis
A Certificate of Analysis (COA) is the primary documentation instrument for verifying compound purity. Key fields to evaluate include:
- Purity (%): The proportion of the target compound as determined by HPLC area percentage. Research-grade compounds are typically specified at 98% or 99% purity or above.
- Molecular Weight: Confirmed by mass spectrometry. Should correspond to the theoretical molecular weight of the target sequence.
- Appearance: Physical description of the lyophilised material (e.g. white to off-white powder), which can indicate gross contamination or degradation.
- Batch Number: Enables traceability to specific synthesis and testing records.
- Testing Laboratory: Accredited third-party laboratories provide independent verification, removing potential conflicts of interest in self-reported purity data.
Astralis Labs Quality Standards
All compounds supplied by Astralis Labs are tested to a minimum purity specification of >99% by HPLC, with mass spectrometry confirmation of molecular identity. Batch-specific COAs are available on our Certificate of Analysis page. We do not release compounds that fail to meet our purity specifications.
Important Notes
All compounds supplied by Astralis Labs are intended strictly for in vitro and laboratory research purposes. This content is provided for scientific reference only and does not constitute medical advice. Not for human consumption or therapeutic use.